RHOEN-KLINIKUM AG (RHK.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:RHK • DE0007042301
13.1 EUR
0 (0%)
Last: Jan 29, 2026, 07:00 PM
We assign a fundamental rating of 5 out of 10 to RHK. RHK was compared to 26 industry peers in the Health Care Providers & Services industry. While RHK has a great health rating, its profitability is only average at the moment. RHK is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- RHK had positive earnings in the past year.
- In the past year RHK had a positive cash flow from operations.
- RHK had positive earnings in each of the past 5 years.
- Each year in the past 5 years RHK had a positive operating cash flow.
1.2 Ratios
- With a Return On Assets value of 2.02%, RHK is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
- RHK has a Return On Equity of 2.90%. This is in the lower half of the industry: RHK underperforms 65.38% of its industry peers.
- With a Return On Invested Capital value of 2.67%, RHK is not doing good in the industry: 73.08% of the companies in the same industry are doing better.
- RHK had an Average Return On Invested Capital over the past 3 years of 2.34%. This is below the industry average of 6.45%.
- The last Return On Invested Capital (2.67%) for RHK is above the 3 year average (2.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.02% | ||
| ROE | 2.9% | ||
| ROIC | 2.67% |
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
1.3 Margins
- Looking at the Profit Margin, with a value of 2.28%, RHK is in line with its industry, outperforming 42.31% of the companies in the same industry.
- In the last couple of years the Profit Margin of RHK has declined.
- Looking at the Operating Margin, with a value of 2.86%, RHK is doing worse than 69.23% of the companies in the same industry.
- RHK's Operating Margin has declined in the last couple of years.
- With a decent Gross Margin value of 66.81%, RHK is doing good in the industry, outperforming 73.08% of the companies in the same industry.
- In the last couple of years the Gross Margin of RHK has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.86% | ||
| PM (TTM) | 2.28% | ||
| GM | 66.81% |
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
2. Health
2.1 Basic Checks
- RHK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, RHK has about the same amount of shares outstanding.
- The number of shares outstanding for RHK remains at a similar level compared to 5 years ago.
- The debt/assets ratio for RHK has been reduced compared to a year ago.
2.2 Solvency
- RHK has an Altman-Z score of 3.09. This indicates that RHK is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of RHK (3.09) is better than 84.62% of its industry peers.
- RHK has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
- RHK's Debt to Equity ratio of 0.09 is amongst the best of the industry. RHK outperforms 96.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.09 |
ROIC/WACC0.4
WACC6.62%
2.3 Liquidity
- RHK has a Current Ratio of 2.28. This indicates that RHK is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 2.28, RHK belongs to the best of the industry, outperforming 96.15% of the companies in the same industry.
- A Quick Ratio of 2.19 indicates that RHK has no problem at all paying its short term obligations.
- RHK has a better Quick ratio (2.19) than 96.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.28 | ||
| Quick Ratio | 2.19 |
3. Growth
3.1 Past
- RHK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.41%.
- Measured over the past 5 years, RHK shows a small growth in Earnings Per Share. The EPS has been growing by 0.03% on average per year.
- Looking at the last year, RHK shows a quite strong growth in Revenue. The Revenue has grown by 9.10% in the last year.
- RHK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.12% yearly.
EPS 1Y (TTM)-15.41%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%3.33%
Revenue 1Y (TTM)9.1%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%8.37%
3.2 Future
- The Earnings Per Share is expected to grow by 11.57% on average over the next years. This is quite good.
- The Revenue is expected to grow by 5.93% on average over the next years.
EPS Next Y4.3%
EPS Next 2Y10.47%
EPS Next 3Y11.09%
EPS Next 5Y11.57%
Revenue Next Year6.74%
Revenue Next 2Y5.36%
Revenue Next 3Y6.5%
Revenue Next 5Y5.93%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 22.98, RHK is valued on the expensive side.
- 61.54% of the companies in the same industry are cheaper than RHK, based on the Price/Earnings ratio.
- RHK's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.39.
- With a Price/Forward Earnings ratio of 17.14, RHK is valued on the expensive side.
- 65.38% of the companies in the same industry are cheaper than RHK, based on the Price/Forward Earnings ratio.
- RHK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 25.72, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.98 | ||
| Fwd PE | 17.14 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, RHK is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.51 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RHK does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.34
PEG (5Y)675.83
EPS Next 2Y10.47%
EPS Next 3Y11.09%
5. Dividend
5.1 Amount
- RHK has a yearly dividend return of 0.76%, which is pretty low.
- RHK's Dividend Yield is slightly below the industry average, which is at 1.72.
- Compared to an average S&P500 Dividend Yield of 1.82, RHK's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.76% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- RHK pays out 17.78% of its income as dividend. This is a sustainable payout ratio.
DP17.78%
EPS Next 2Y10.47%
EPS Next 3Y11.09%
RHOEN-KLINIKUM AG / RHK.DE FAQ
Can you provide the ChartMill fundamental rating for RHOEN-KLINIKUM AG?
ChartMill assigns a fundamental rating of 5 / 10 to RHK.DE.
What is the valuation status of RHOEN-KLINIKUM AG (RHK.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to RHOEN-KLINIKUM AG (RHK.DE). This can be considered as Overvalued.
Can you provide the profitability details for RHOEN-KLINIKUM AG?
RHOEN-KLINIKUM AG (RHK.DE) has a profitability rating of 4 / 10.
Can you provide the financial health for RHK stock?
The financial health rating of RHOEN-KLINIKUM AG (RHK.DE) is 7 / 10.
How sustainable is the dividend of RHOEN-KLINIKUM AG (RHK.DE) stock?
The dividend rating of RHOEN-KLINIKUM AG (RHK.DE) is 2 / 10 and the dividend payout ratio is 17.78%.